Study of a High-Risk Group of Stage II Colon Cancer

被引:0
|
作者
Hirosawa, Tomoichiro [1 ]
Itabashi, Michio [1 ]
Bamba, Yoshiko [1 ]
Ogawa, Shinpei [1 ]
Sirotani, Noriyasu [1 ]
Kameoka, Shingo [1 ]
机构
[1] Tokyo Womens Med Univ, Dept Surg 2, Sch Med, Sinjuku Ku, Tokyo 1628666, Japan
关键词
Colon cancer; Stage II; Adjuvant chemotherapy; RECTAL-CANCER; EFFICACY; FLUOROURACIL; TRIAL;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
This study was conducted for the purpose of identifying a high-risk group for recurrence of stage II colon cancer and determine those cases for which postoperative adjuvant chemotherapy for stage II colon cancer is indicated. The subjects of this study consisted of 179 stage II cases and 114 stage IIIa cases among 462 surgical colon cancer cases examined at this department from January 1, 1991 to December 31, 1996 classified as A for the degree of cure, with the exception of m cancer. A nonrecurrence group and a recurrence group of stage II and stage IIIa colon cancer cases were compared on the basis of parameters. Gender, age, and lymph ducts were extracted from multivariate analysis, while age and lymph ducts were extracted from a survival analysis using the Cox proportional hazard model. A high-risk group for recurrence of stage II colon cancer was determined to consist of young men of ly 2.3. Since the nonrecurrence survival rates and survival prognoses of ly 2.3 cases in particular were equivalent to those of stage IIIa, this is considered to be a risk factor for recurrence of stage II colon cancer, and postoperative chemotherapy is believed to be indicated.
引用
收藏
页码:130 / 135
页数:6
相关论文
共 50 条
  • [41] Chemoradiotherapy for high-risk stage II laryngeal cancer
    Satoshi Hamauchi
    Tomoya Yokota
    Yusuke Onozawa
    Hirofumi Ogawa
    Tsuyoshi Onoe
    Tomoyuki Kamijo
    Yoshiyuki Iida
    Tetsuro Onitsuka
    Hirofumi Yasui
    International Journal of Clinical Oncology, 2020, 25 : 1596 - 1603
  • [42] Chemoradiotherapy for high-risk stage II laryngeal cancer
    Hamauchi, Satoshi
    Yokota, Tomoya
    Onozawa, Yusuke
    Ogawa, Hirofumi
    Onoe, Tsuyoshi
    Kamijo, Tomoyuki
    Iida, Yoshiyuki
    Onitsuka, Tetsuro
    Yasui, Hirofumi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (09) : 1596 - 1603
  • [43] Duration of FOLFOX Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer With Deficient Mismatch Repair
    Hu, Huabin
    Wu, Zehua
    Wang, Chao
    Huang, Yan
    Zhang, Jianwei
    Cai, Yue
    Xie, Xiaoyu
    Li, Jianxia
    Shen, Cailu
    Li, Weiwei
    Ling, Jiayu
    Xu, Xuehu
    Deng, Yanhong
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [44] Cost-effectiveness of adjuvant chemotherapy for high-risk stage II and stage III colon cancer in South Africa
    Tan, Sarah Xinhui
    Pumpalova, Yoanna
    Rogers, Alexandra M. M.
    Bhatt, Kishan
    Herbst, Candice-lee
    Ruff, Paul
    Neugut, Alfred I. I.
    Hur, Chin
    CANCER MEDICINE, 2023, 12 (14): : 15515 - 15529
  • [45] Association of NCCN guideline adherence with improved survival in high-risk stage II and stage III colon cancer.
    Boland, Genevieve Marie
    Chiang, Yj
    Chagpar, Ryaz
    Xing, Yan
    Hu, Chung-Yuan
    Feig, Barry W.
    Chang, George J.
    You, Y. Nancy
    Cormier, Janice N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [46] The clinical dilemma of high-risk stage II colon cancer: are we truly prepared to withdraw oxaliplatin?
    Taieb, J.
    Gandini, A.
    Seligmann, J. F.
    Gallois, C.
    ESMO OPEN, 2024, 9 (12)
  • [47] Use of a combination of CEA and tumor budding to identify high-risk patients with stage II colon cancer
    Du, Changzheng
    Xue, Weicheng
    Dou, Fangyuan
    Peng, Yifan
    Yao, Yunfeng
    Zhao, Jun
    Gu, Jin
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2017, 32 (03): : E267 - E273
  • [48] Predictive modelling for high-risk stage II colon cancer using auto-artificial intelligence
    Tetsuo Ishizaki
    Junichi Mazaki
    Masanobu Enomoto
    Ryutaro Udo
    Tomoya Tago
    Kenta Kasahara
    Yuichi Nagakawa
    Techniques in Coloproctology, 2023, 27 : 183 - 188
  • [49] Predictive modelling for high-risk stage II colon cancer using auto-artificial intelligence
    Ishizaki, Tetsuo
    Mazaki, Junichi
    Enomoto, Masanobu
    Udo, Ryutaro
    Tago, Tomoya
    Kasahara, Kenta
    Nagakawa, Yuichi
    TECHNIQUES IN COLOPROCTOLOGY, 2023, 27 (03) : 183 - 188
  • [50] High-risk MSI-H stage II colon cancer: Treatment patterns and outcomes.
    Fleming, Patrick
    Chen, Chunxia
    Moore, Dirk F.
    Hochster, Howard S.
    Jabbour, Salma K.
    Berim, Lyudmyla Derby
    Spencer, Kristen Renee
    Gulhati, Pat
    Donohue, Kristen
    Patel, Nell Maloney
    Boland, Patrick M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15587 - E15587